Spinalon

In our post in September 2013 we have announced possibility for further development and possible human trial for this drug.
Spinalon will affect walking pattern generator in spinal cord on the way to produce short outburst of involuntary walking motion that will last for 30 – 40 minutes.
This drug have no ability to recover or reconnect damaged nerves and patients (chronic para and quadriplegic Spinal Cord Injuries) will be able to walk just @ controlled treadmill environment.

nordic
More details about this trial in Press Release and
Blog Spinal Cord Injuries Research & Advocacy.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s